 | Staurosporine | IC50 | 33.0 [1] |
| Staurosporine | Ki | 22.0 [1] |
 | N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | IC50 | 104.0 [1] |
| N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | Ki | 38.0 [1], 770.0 [2] |
 | 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione | IC50 | 33.88 [1] |
 | 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | IC50 | 1500.0 [1] |
 | Alsterpaullone | IC50 | 4.0 [1] |
 | Kenpaullone | IC50 | 23.0 [1] |
 | Hymenialdisine | IC50 | 10.0 [1] |
 | 3-(3-Chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | IC50 | 77.0 [1], 78.0 [2], 90.0 [3], 104.0 [4], 380.0 [5] |
| 3-(3-Chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | Ki | 24.0 [1] |
 | Manzamine A | IC50 | 10200.0 [1] |
 | Chir-99021 | IC50 | 4.9 [1], 7.0 [2], 30.0 [3] |
 | Indirubin-3'-monoxime | IC50 | 22.0 [1], 200.0 [2] |
 | Tideglusib | IC50 | 60.0 [1], 78.0 [2], 1000.0 [3], 2000.0 [4] |
 | LY-2090314 | IC50 | 0.7 [1], 0.9 [2], 1.1 [3] |
 | Paullone | IC50 | 4.0 [1], 100.0 [2], 619.44 [3], 620.0 [4] |
 | 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 650.0 [1], 1500.0 [2] |
 | GSK-3 Inhibitor II | IC50 | 390.0 [1], 790.0 [2] |
 | 3-Imidazo[1,2-a]pyridin-3-yl-4-[10-(morpholine-4-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]pyrrole-2,5-dione | IC50 | 1.3 [1], 2.6 [2] |
 | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 71.0 [1], 1000.0 [2], 1100.0 [3] |
 | 5-Iodo-Indirubin-3'-monoxime | IC50 | 9.0 [1] |
 | 3-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxopyrrol-3-yl)-N,N-dimethyl-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraene-10-carboxamide | IC50 | 1.6 [1], 12.0 [2] |
 | Bisindolylmaleimide IX | IC50 | 2.8 [1], 3.0 [2], 38.0 [3] |
 | 2,4'-Dibromoacetophenone | IC50 | 500.0 [1] |
 | Indirubin | IC50 | 4.0 [1], 5.0 [2], 600.0 [3] |
 | 2-Chloroacetophenone | IC50 | 50000.0 [1] |
 | 2-Bromoacetophenone | IC50 | 5000.0 [1] |
 | 2-Bromo-4'-chloroacetophenone | IC50 | 1000.0 [1] |
 | 4-(1H-Indol-3-yl)pyrimidin-2-amine | IC50 | 14810.0 [1], 350000.0 [2] |
 | 2-Bromo-4'-nitroacetophenone | IC50 | 2000.0 [1] |
 | 2,4'-Dichloroacetophenone | IC50 | 2500.0 [1] |
 | 2-Bromo-4'-methoxyacetophenone | IC50 | 1000.0 [1] |
 | 9-Cyanopaullone | IC50 | 10.0 [1] |
 | 2-Chloro-5-[4-(3-chloro-phenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-ylamino]-benzoic acid | IC50 | 76.0 [1], 160.0 [2] |
 | Palinurin | IC50 | 2600.0 [1], 4500.0 [2] |
 | Pyrazolo[1,5-b]pyridazine deriv. 16 | IC50 | 32.0 [1] |
| Pyrazolo[1,5-b]pyridazine deriv. 16 | Ki | 10.0 [1], 19.0 [2] |
 | 2-Chloro-1-(4,5-dibromo-2-thiophenyl)ethanone | IC50 | 1000.0 [1] |
 | CID 9957049 | IC50 | 0.56 [1], 0.58 [2], 0.6 [3] |
 | 4-[5-(Piperidin-1-ylmethyl)-4-(3-pyridin-4-yl-1H-1,2,4-triazol-5-yl)triazol-1-yl]-1,2,5-oxadiazol-3-amine | IC50 | 280.0 [1] |
 | 2-Chloro-1-(3,4-dibromo-2-thienyl)-1-ethanone | IC50 | 500.0 [1] |
 | Paullone Analog 46 | IC50 | 10000.0 [1] |
 | N'-Dodecanoyl-1-ethyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide | IC50 | 2800.0 [1], 3010.0 [2] |
 | 4-Acylamino-6-arylfuro[2,3-d]pyrimidine 24 | IC50 | 5.0 [1] |
 | 20-Ethyl-17,23-dioxa-4,14,20,26-tetrazahexacyclo[24.6.1.17,14.02,6.08,13.027,32]tetratriaconta-1(33),2(6),7(34),8,10,12,27,29,31-nonaene-3,5-dione | IC50 | 18.0 [1], 25.0 [2] |
 | 3-Imidazo[1,2-a]pyridin-3-yl-4-[10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]pyrrole-2,5-dione | IC50 | 1.6 [1], 2.0 [2] |
 | N-[3-[2-Methyl-4-(3-methylphenyl)piperazin-1-yl]propyl]-3-pyridin-3-yl-1,2,4-oxadiazole-5-carboxamide | IC50 | 200.0 [1], 690.0 [2], 17000.0 [3] |
 | 5-(4-Methoxyphenyl)-N-(Pyridin-4-Ylmethyl)-1,3-Oxazole-4-Carboxamide | IC50 | 79.43 [1], 398.11 [2], 1995.26 [3] |
 | 7-(4-Morpholin-4-ylphenyl)-2-pyridin-4-yl-5H-thieno[3,2-c]pyridin-4-one | IC50 | 63.1 [1], 501.19 [2], 1258.93 [3] |
 | N-[[1-[(2,4-Dichlorophenyl)methyl]piperidin-4-yl]methyl]-5-methoxy-1H-indazole-3-carboxamide | IC50 | 310.0 [1], 1390.0 [2] |
 | 5-(2,3-Difluorophenyl)-N-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-1H-indazole-3-carboxamide | IC50 | 18.0 [1], 240.0 [2] |
| 5-(2,3-Difluorophenyl)-N-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-1H-indazole-3-carboxamide | Ki | 15.0 [1] |
 | Methyl 2-[[4-[[(5-methoxy-1H-indazole-3-carbonyl)amino]methyl]piperidin-1-yl]methyl]-1,3-oxazole-4-carboxylate | IC50 | 210.0 [1], 5170.0 [2] |
 | 5-[[4-[[[5-(6-Methoxypyridin-3-yl)-1H-indazole-3-carbonyl]amino]methyl]piperidin-1-yl]methyl]furan-2-carboxylic acid | IC50 | 20.0 [1], 21.0 [2], 70800.0 [3] |
 | Methyl 2-[[4-[[(5-methoxy-1H-indazole-3-carbonyl)amino]methyl]piperidin-1-yl]methyl]-1,3-thiazole-4-carboxylate | IC50 | 130.0 [1], 2130.0 [2] |
 | Methyl 2-[[4-[[(5-methoxy-1H-indazole-3-carbonyl)amino]methyl]piperidin-1-yl]methyl]furan-3-carboxylate | IC50 | 230.0 [1], 820.0 [2] |
 | 2-[[4-[[[5-(2,3-Difluorophenyl)-1H-indazole-3-carbonyl]amino]methyl]piperidin-1-yl]methyl]-1,3-oxazole-4-carboxylic acid | IC50 | 6.0 [1], 10.0 [2], 100000.0 [3] |
 | Lithium | IC50 | 6530.0 [1], 2000000.0 [2] |
 | Bisindolylmaleimide i | IC50 | 190.0 [1], 190.55 [2] |
 | 6-Bromoindirubin-3'-oxime | IC50 | 174.0 [1], 1500.0 [2] |
 | 1-Azakenpaullone | IC50 | 18.0 [1] |
 | 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine | IC50 | 660.0 [1], 3000.0 [2] |
 | 3-(2-Aminopyrimidin-4-yl)-1H-indol-4-ol | IC50 | 1300.0 [1] |
 | N-(5-Methyl-1H-pyrazol-3-yl)-2-phenylquinazolin-4-amine | Ki | 22.0 [1] |
 | 4-(5-Bromo-1H-indol-3-yl)pyrimidin-2-amine | IC50 | 2000.0 [1] |
 | Cdk1/2 Inhibitor III | IC50 | 140.0 [1], 210.0 [2] |
 | Pyridine, 4-[5-[(phenylmethyl)thio]-1,3,4-oxadiazol-2-yl]- | IC50 | 1318.0 [1], 6700.0 [2] |
 | N-[5-Bromo-6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 7.0 [1] |
 | GSK-3beta Inhibitor xi | IC50 | 5.0 [1], 25.0 [2] |
 | 2-Bromo-4'-phenylacetophenone | IC50 | 2500.0 [1] |
 | 2-(Phenylamino)-3-phenylmaleimide | IC50 | 520.0 [1], 590.0 [2] |
 | 4-Arylmaleimide deriv. 6-l | IC50 | 20.0 [1] |
 | 4-(4-Hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(1H)-one | IC50 | 17.2 [1], 5280.0 [2] |
 | (Z)-5-((1H-Indol-3-yl)methylene)thiazolidine-2,4-dione | IC50 | 4930.0 [1], 21000.0 [2] |
 | Indazole analogue 12 | IC50 | 15.0 [1], 100.0 [2] |
 | 3-(Benzofuran-3-yl)-4-(5-bromo-1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione | IC50 | 7.0 [1], 21.1 [2] |
 | 7,12-Dihydro-9-(trifluoromethyl)indolo[3,2-d][1]benzazepine-6(5H)-one | IC50 | 29.99 [1], 30.0 [2] |
 | Pyrazolopyridazine 1 | Ki | 10.0 [1] |
 | Pyrazolo[1,5-b]pyridazine deriv. 22 | IC50 | 16.0 [1] |
| Pyrazolo[1,5-b]pyridazine deriv. 22 | Ki | 30.0 [1] |
 | N-[6-(3-Hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 8.0 [1], 12.0 [2] |
 | 9-Methyl-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one | IC50 | 130.0 [1], 130.02 [2] |
 | [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine | Ki | 20.0 [1] |
 | Thieno analogue of kenpaullone | IC50 | 119.95 [1], 120.0 [2] |
 | 4-Benzyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione | IC50 | 7000.0 [1], 7149.0 [2] |
 | 1-(3-Methoxyphenyl)-N-[(E)-pyridin-4-ylmethylideneamino]pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 6.31 [1], 16.0 [2] |
 | Indolylylmaleimide 1 | IC50 | 16.98 [1], 17.0 [2] |
 | 9-Chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one | IC50 | 23.99 [1], 24.0 [2] |
 | 11-Chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one | IC50 | 199.99 [1], 200.0 [2] |
 | 9-Fluoro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one | IC50 | 79.98 [1], 80.0 [2] |
 | 9-Bromo-4-hydroxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5h)-one | IC50 | 4295.36 [1], 4300.0 [2] |
 | 2,3-Dimethoxy-7,12-dihydro-9-bromoindolo[3,2-d][1]benzazepine-6(5H)-one | IC50 | 100.0 [1] |
 | 4-Methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5h)-one | IC50 | 139958.73 [1], 140000.0 [2] |
 | 9-Bromo-4-methoxy-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5h)-one | IC50 | 15995.58 [1], 16000.0 [2] |
 | 2,3-Dimethoxy-7,12-dihydro-9-(trifluoromethyl)indolo[3,2-d][1]benzazepine-6(5H)-one | IC50 | 74.99 [1], 75.0 [2] |
 | 8,10-Dichloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5h)-one | IC50 | 5000.0 [1], 5000.35 [2] |
 | 3-(1-Methylindol-3-yl)-4-[1-(3-morpholin-4-ylpropyl)pyrazolo[3,4-b]pyridin-3-yl]pyrrole-2,5-dione | IC50 | 340.0 [1], 750.0 [2] |
 | Paullone Analog 22 | IC50 | 399.94 [1], 400.0 [2] |
 | Paullone Analog 39 | IC50 | 2098.94 [1], 2100.0 [2] |
Calculator
